Yasuyuki Arai1, Takamitsu Tsukahara2, Kana Matsumoto3, Miki Nagao4, Tadakazu Kondo1, Akifumi Takaori1 (1.Department of Hematology and Oncology, Kyoto University, Kyoto, Japan, 2.Institute of Nutrition & Pathology Inc., Kyoto, Japan, 3.Doshisha Women's College of Liberal Arts, Kyoto, Japan, 4.Department of Infectious Control and Prevention, Kyoto University, Kyoto, Japan)
Session information
Oral Session
Oral Session 3-14C GVHD (3)
Sun. Oct 13, 2019 2:30 PM - 3:30 PM No.14 (Tokyo International Forum, 6F G610)
Chair: Makoto Murata (Department of Hematology and Oncology, Nagoya University Graduate School of Medicine)
Takaaki Konuma1, Chisato Kohara1, Eri Watanabe2, Shunsuke Takahashi3, Genki Ozawa3, Kei Suzuki3, Motoko Mizukami4, Etsuko Nagai4, Koji Jimbo1, Yuta Kaito1, Masamichi Isobe1, Seiko Kato1, Satoshi Takahashi1, Arinobu Tojo1 (1.Hematol., IMSUT, University of Tokyo, Tokyo, Japan, 2.FACS Lab., IMSUT, University of Tokyo, Tokyo, Japan, 3.Techno Suruga Laboratory Co., Ltd., Shizuoka, Japan, 4.Laboratory Med., IMSUT, University of Tokyo, Tokyo, Japan)
Masahide Osaki1, Yosuke Domon1, Kenichiro Takeda1, Kohei Ishigiwa1, Tomoe Ichiki1, Yuka Kawaguchi1, Motohito Okabe1, Rena Matsumoto1, Marie Ohbiki1, Ai Ito2, Tatsunori Goto1, Takanobu Morishita1, Yukiyasu Ozawa1, Masafumi Ito2, Koichi Miyamura1 (1.Department of Hematology, Japanese Red Cross Nagoya First Hospital, 2.Department of Pathology, Japanese Red Cross Nagoya First Hospital)
Kaoru Morita, Shinichiro Fujiwara, Hirotomo Nakashima, Shinichiro Kawaguchi, Yumiko Toda, Shoko Ito, Shinichi Ochi, Takashi Nagayama, Kiyomi Mashima, Kento Umino, Daisuke Minakata, Hirofumi Nakano, Ryoko Yamasaki, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Kazuo Muroi, Yoshinobu Kanda (Division of Hematology, Jichi Medical University, Tochigi, Japan)
Junichi Mukae1, Kyoko Inamoto1, Kazuhiko Kakihana1, Toshimitsu Ueki2, Yuko Kiridoshi3, Kozue Takeshita4, Wataru Suda7, Yuki Fujioka5,6, Atsushi Wada1, Hiroto Adachi1, Ryosuke Konuma1, Yuya Kishida1, Akihito Nagata1, Yuta Yamada1, Tatsuya Konishi1, Kota Yoshifuji1, Takashi Toya1, Aiko Igarashi1, Yuho Najima1, Takeshi Kobayashi1, Noriko Doki1, Atsushi Shiota3,4, Hiroyoshi Nishikawa5, Masahira Hattori7,8, Kenya Honda4,7, Hisashi Sakamaki1, Kazuteru Ohashi1 (1.Hematology Division, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan, 2.Department of Hematology, Nagano Red Cross Hospital, 3.JSR-Keio University Medical and Chemical Innovation Center (JKiC), 4.Department of Microbiology and Immunology, Keio University School of Medicine, 5.Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 6.Department of Hematology, Nephrology, and Rheumatology, Akita University, 7.RIKEN Center for Integrative Medical Sciences (IMS), 8.Graduate School of Advanced Science and Engineering, Waseda University)
Atsushi Wada, Noriko Doki, Hiroto Adachi, Ryosuke Konuma, Masahiro Fujita, Yuya Kishida, Tatsuya Konishi, Akihito Nagata, Yuta Yamada, Satoshi Kaito, Takuma Kumagai, Kota Yoshifuji, Junichi Mukae, Megumi Akiyama, Kyoko Inamoto, Takashi Toya, Aiko Igarashi, Yuho Najima, Takeshi Kobayashi, Kazuhiko Kakihana, Hisashi Sakamaki, Kazuteru Ohashi (Hematol., Komagome Hospital., Tokyo, Japan)